SURGICEL SNoW™ Absorbable Hemostat

SURGICEL SNoW Hemostat helps you focus on the procedure, not the bleed. With enhanced speed, handling and performance, one layer is more elective than four layers of SURGICEL® Original Absorbable Hemostat.

SURGICEL SNoW™ Absorbable Hemostat

Features & Benefits

  • Proven bactericidal advantage graph

    Proven bactericidal advantage

    SURGICEL® is bactericidal in vitro against a wide range of organisms. The SURGICEL® Family of Absorbable Hemostats is the first and only absorbable hemostat proven bactericidal against a broad range of gram-positive and gram-negative organisms including various antibiotic resistant bacteria (MRSA, VRE, PRSP and MRSE).¹*†

    †The clinical benefit of these bactericidal claims has not been studied or demonstrated.

  • Faster time to hemostasis‡

    Faster time to hemostasis

    Expedite hemostasis with Oxidized Regenerated Cellulose (ORC). SURGICEL SNoW Hemostat initiates hemostasis by serving as a scaffold for platelet adhesion and aggregation that leads to quick clot formation.³ SURGICEL SNoW Hemostat provides superior hemostasis compared to SURGICEL Original Hemostat (43% faster time to hemostasis [TTH]) with reproducible performance among specialties and procedures.

  • Superior conformability and handling

    Superior conformability and handling

    Non-woven structure increases surface contact to bleeding site.² With enhanced conformability and superior handling vs. SURGICEL Original Hemostat, SURGICEL SNoW Hemostat is easy to deploy and manipulate in laparoscopic surgery. Its non-woven structure increases surface contact to bleeding site.²

Product Specifications

Product Code Product Code Description 
2081 2081 Structured non-woven fabric, needle punched with interlocking fibers 
2082 2082 Structured non-woven fabric, needle punched with interlocking fibers 
2083 2083 Structured non-woven fabric, needle punched with interlocking fibers 

Product Resources

Resources

SURGICEL Mechanism of Action

Supporting Documentation

Resources

SURGICEL SNoW™
Absorbable
Hemostat IFU

References

* Methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), penicillin-resistant Streptococcus pneumoniae (PRSP), methicillin-resistant Staphylococcus epidermidis (MRSE)

‡ Compared to SURGICEL® Original Absorbable Hemostat

1. Bhende S. In vitro evaluation of bactericidal properties of SNoW (SURGICEL non-woven) samples against several bacterial strains. June 14, 2010. Ethicon, Inc.

2. Helms JM. Ethicon Biosurgery SNoW Marketing Claims Report. July 12, 2010. Ethicon, Inc.

3. SURGICEL® Absorbable Hemostat Full Prescribing Information. Ethicon, Inc. Helms JM. Ethicon Biosurgery SNoW Marketing Claims Report. July 12, 2010. Ethicon, Inc. SURGICEL® Essential Product Information

INDICATIONS

SURGICEL® Absorbable Hemostat (oxidized regenerated cellulose) is used adjunctively in surgical procedures to assist in the control of capillary, venous, and small arterial hemorrhage when ligation or other conventional methods of control are impractical or inelective. SURGICEL® ORIGINAL, SURGICEL® FIBRILLAR™, SURGICEL® NU-KNIT®, and SURGICEL® SNoW™ Absorbable Hemostats can be cut to size for use in endoscopic procedures.

PRECAUTIONS

Use only as much SURGICEL® Absorbable Hemostat as is necessary for hemostasis, holding it firmly in place until bleeding stops. Remove any excess before surgical closure in order to facilitate absorption and minimize the possibility of foreign body reaction.

In urological procedures, minimal amounts of SURGICEL® Absorbable Hemostat should be used and care must be exercised to prevent plugging of the urethra, ureter, or a catheter by dislodged portions of the product.

Since absorption of SURGICEL® Absorbable Hemostat could be prevented in chemically cauterized areas, its use should not be preceded by application of silver nitrate or any other escharotic chemicals.

If SURGICEL® Absorbable Hemostat is used temporarily to line the cavity of large open wounds, it should be placed so as not to overlap the skin edges. It should also be removed from open wounds by forceps or by irrigation with sterile water or saline solution after bleeding has stopped.

Precautions should be taken in otorhinolaryngologic surgery to assure that none of the material is aspirated by the patient. (Examples: controlling hemorrhage after tonsillectomy and controlling epistaxis).

Care should be taken not to apply SURGICEL® Absorbable Hemostat too tightly when it is used as a wrap during vascular surgery (see Adverse Reactions section of the complete product package insert).

ADVERSE EVENTS

“Encapsulation” of fluid and foreign body reactions have been reported.

There have been reports of stenotic elect when SURGICEL® Absorbable Hemostat has been applied as a wrap during vascular surgery.

Paralysis and nerve damage have been reported when SURGICEL® Absorbable Hemostat was used around, in, or in proximity to foramina in bone, areas of bony confine, the spinal cord, and or the optic nerve and chiasm.

Blindness has been reported in connection with surgical repair of a lacerated left frontal lobe when SURGICEL® Absorbable Hemostat was placed in the anterior cranial fossa.

Possible prolongation of drainage in cholecystectomies and difficulty passing urine per urethra after prostatectomy have been reported.

For more information, please consult your doctor or for product quality and technical questions, call 1-800-795-0012. For complete product information including indications, contraindications, warnings, precautions, and adverse reactions, please reference the individual product package inserts.

110002-190321